Efficacy and Cerebrospinal Fluid Rhinorrhea after Cabergoline Treatment in Patients with Bioactive Macroprolactinoma

SIMPLE SUMMARY: Predicting dopamine agonist resistance in patients with macroprolactinoma is essential for clinicians to prevent treatment failure and subsequent complications such as medication–induced cerebrospinal fluid (CSF) rhinorrhea. In this retrospective cross-sectional study that included 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hae-Kyung, Hong, Jae-Won, Moon, Ju-Hyung, Ahn, Sung-Soo, Kim, Eui-Hyun, Lee, Seung-Koo, Lee, Eun-Jig, Park, Yae-Won, Ku, Cheol-Ryong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582509/
https://www.ncbi.nlm.nih.gov/pubmed/34771538
http://dx.doi.org/10.3390/cancers13215374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582509/
https://www.ncbi.nlm.nih.gov/pubmed/34771538
http://dx.doi.org/10.3390/cancers13215374

Ejemplares similares